within Pharmacolibrary.Drugs.ATC.A;

model A16AX09
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.77,
    Cl             = 4.5833333333333334e-05,
    adminDuration  = 600,
    adminMass      = 9000 / 1000000,   // mg â†’ kg
    adminCount     = 1,
    Vd             = 0.0064,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.008666666666666666,
    Tlag           = 2400
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>A16AX09</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Glycerol phenylbutyrate is a prodrug for phenylbutyric acid, approved for chronic management of urea cycle disorders. It is used to help control hyperammonemia by delivering phenylacetate, which serves as a nitrogen scavenger. The drug is currently approved and marketed for use in both pediatric and adult populations with urea cycle disorders.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters from published clinical studies in healthy adults and patients with urea cycle disorders. Most data are for oral administration of therapeutic doses.</p><h4>References</h4><ol></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end A16AX09;
